20n Bio is a VC-backed start-up dedicated to the computational design of novel protein therapeutics.

Accelerated Biosciences Corp. is commercializing human trophoblast stem cells isolated from the trophectoderm of embryos from women with ectopic pregnancies.

Aclipse Therapeutics is focused on developing novel and highly differentiated drugs to address diseases with high unmet medical needs.

AgroFresh is an AgTech innovator and global leader

AlloVir is the leader in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases.

A U.S. based biotechnology company specializing in antibody labeling reagents.

Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines.

ATGC Inc. (ATGC) is “A Translational Genomics Company” dedicated to the development of novel transgenic rabbits as discovery platforms and bioreactors

Biocognon’s mission is delivering molecular recognition technology for faster and cheaper creation of effective antibody-based therapeutics and diagnostics.

BioCurie is developing artificial intelligence (AI) - driven SaaS solutions that enable the development and manufacture of gene and cell therapies

Founded in 1978, Biogen is a leading global biotechnology company that has pioneered multiple breakthrough innovations

Biohaven is a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies

BHS’ vision is to deliver safe and effective biologic drugs to patients everywhere.

Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery.

BlueSphere Bio was founded to unlock the potential of personalized T cell therapy for the treatment of cancer  

Bound Therapeutics is a biotech company that utilizes a cancer cell-specific drug delivery system.

BreakSight, Inc is a biotech company that specializes in DNA break capture, genomics analyses, and DNA sequence marker identification.

Cabaletta Bio is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies

Carisma Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing immunotherapies to treat cancer and other diseases. 

Catemer is focused on the development of synthetic polymer and macrocyclic polyester compounds developed for therapeutic purposes. 

Biotechnology company developing products for treatment of hematological and solid tumor malignancies

Chimeron is biotech company focused on developing personalized gene therapies starting with cancer

ChromaTan develops continuous countercurrent tangential chromatography for monoclonal antibody and protein purification.

Genomics company that enables cis-regulatory modules (CRMs) such as enhancers and promoters for drug development, precision medicine, and biotechnology.

Code Bio is developing transformational, non-viral, genetic medicines to treat and potentially cure serious and life-threatening diseases

Coeptis Therapeutics Inc. together with its subsidiaries, is a clinical stage biotechnology company developing innovative cell therapies for patients with cancer

Cook Myosite creates specialized treatments for patients, using their own muscle cells in a procedure that begins and ends with the patient's own body. 

CRADL® provides leasable, AAALAC-accredited, turnkey vivarium space and in vivo support services for researchers

Harnessing the immune system to reimagine cancer therapy

EmphyCorp Inc. is a Private Biotech that specializes in Nasal Sprays for Respiratory, COVID-19, COVID-19 Long COVID, Flu and more.

Exelixis is a oncology-focused biotechnology company that strives to accelerate the discovery, development, and commercialization of new medications for cancer.

Our goal is to improve the experience and long-term outcomes (both functional and cosmetic) of skin and soft tissue injury repair.

Gylden is a clinical-stage, privately held biotechnology company pioneering the development of 100% synthetic, T cell-priming vaccines/immunotherapies.

iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet need.

IGM Biosciences is a clinical-stage biotechnology company pioneering the development of engineered IgM antibodies

ImmunoGenesis develops science-driven immune therapies specifically designed to treat tumors lacking activated T cells

ImmunoRestoration’s vaccine helps women fight breast cancer by rejuvenating their own immune system

ImmuNovX Biotech is an early-stage company whose mission is to develop the technology we call LR3N-CS

Impact Proteomics provides protein, peptide, and proteome sample preparation and cleanup.

Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies.

Interius BioTherapeutics is an early-stage biotechnology company expanding the potential of cell and gene therapy

Iovance Biotherapeutics aims to improve patient care by making T cell-based immunotherapies

KaliVir Immunotherapeutics is a privately held biotech company

Krystal Biotech, Inc. is using gene therapy to develop effective and novel treatments for skin diseases

Chondrial Therapeutics, LLC was formed to discover and develop orphan drugs for mitochondrial diseases

LI-COR Biosciences designs, manufactures, and markets instruments for biological and environmental research.

Lipella is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of lipid-based therapies

LyGenesis is a clinical-stage biotechnology company whose cell therapies use patients’ lymph nodes as bioreactors to regrow functioning ectopic organs

Magee-Womens Research Institute is an independent research institute

an immunotherapeutic animal health company focused on the use its innovative T-Max DNA Vaccine platform to create disruptive products for infectious diseases

MetasTx is developing a pipeline of novel cancer agents targeted at specific solid tumors based on advances in the delivery of IPA-3

MS2 Array's proprietary HT-MS technology is based on the unique properties of perfluorocarbon molecules known as fluorous partitioning.

NanoCell Therapeutics, Inc. is a company developing a new biological entity-based targeted gene therapy platform.

Neuraptive is creating innovative novel therapies for nerve repairs to improve clinical outcomes for patients and surgeons who care for them.

Noveome Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing next-generation biologic therapeutics.

NRx Pharmaceuticals draws upon decades of collective experience applying innovative science to improved health to patients.

OCMS Bio, LLC provides innovative solutions to a long-vexing problem in biopharmaceutical discovery and manufacturing

Orchard is a research and clinical development involving hematopoietic stem cell, or HSC, gene therapy.

Pall Corporation is a proven partner providing filtration, separation and purification solutions to meet the demanding needs of customers around the globe.

Palvella is a biopharmaceutical company committed to serving patients with debilitating rare, genetic diseases through the development of targeted therapies.

Panavance Therapeutics Inc, a clinical stage biotechnology company focused on novel oncology therapeutics.

Panorama Medicine's proprietary platforms integrate genomics, drug screening, big data, and artificial intelligence to develop therapeutic interventions for RNA

Passage Bio is driven by a focused mission: to offer life-transforming therapies for individuals with CNS disorders 

Phio is developing a pipeline of RNA inference (RNAi) therapies with a focus on oncology, targeting both tumor and immune cells.

Pleopharma focuses on both Cannabis Use Disorder and Cannabis Withdrawal Syndrome. 

Primera Genotech is a startup company developing a platform technology in gene therapy, particularly for adeno-associated virus (AAV) research and development.

Prolifagen LLC is focusing on pre-clinical and early clinical development of a groundbreaking, microRNA-based approach to regeneration of damaged organs

Proteovant is a pioneering protein degradation company focused on discovering and developing transformative medicines.

Pulmotect is pioneering an immunomodulatory and “pathogen agnostic” approach to preventing and treating respiratory complications. 

Qnapsyn Biosciences develops novel pharmaceutical leads targeting autoimmune, metabolic, and neurological disorders.

Radiant Biotherapeutics is advancing a first in class biologic platform that creates modular multivalent therapeutics. 

Raven Biomaterials is a cell and gene therapy manufacturer startup in Bethlehem.

Recombination Therapeutics is a Philadelphia based, discovery stage precision medicine company developing cancer therapeutics

SAB Technology Inc. is a boutique biotech firm dedicated to designing and manufacturing high quality viral vectors.

Script Biosciences is an early stage biotechnology company committed to developing safe, efficient, and durable cures for genetic diseases

Seneca Therapeutics, Inc. (Seneca) is pursuing the development of an oncolytic immunotherapeutic called Seneca Valley Virus (SVV)

Serentrix is focused on developing novel therapies for pain to address opioid epidemic.

SIRPant Immunotherapeutics Inc is a biotechnology company developing a novel autologous cell therapy for solid tumors.

Solesis is an innovative provider of biomaterials solutions and services primarily focused on the MedTech and Biopharma industries

The ISOPROG-Somatolink Expert Patients-for-Patients Research network is an Italian-American non-profit dual organization

 Talee has developed a novel transgene and a number of innovations in multiple viral vectors that collectively will overcome challenges

SwanBio Therapeutics is a gene therapy company developing leading-edge medicines to deliver dramatic clinical efficacy

Syndax Pharmaceuticals is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies

Synergy Therapeutics is developing ch-p53HSA.

SyzOnc aims to develop therapies for cancer patients who have no effective treatment options.

Tavotek is an innovative technology research and development company founded by senior scientists from top multinational pharmaceutical companies

TheracosBio is a pharmaceutical company located in Marlborough, Massachusetts

Tmunity is a unique biotherapeutics company because of the unrivaled depth of its scientific founders’ and management team’s experience

T-NanoBio Therapeutics, Inc. is a biotechnology company developing an innovative therapeutic platform based on transformable peptide nanoparticles.

Treovir is committed to ensuring access and affordability for all patients .

Trevarx Biomedical discovers and develops novel radiopharmaceutical platforms that turn deadly diseases into manageable conditions.

a biopharmaceutical company committed to bringing to patients novel products for the treatment of rare and ultra-rare diseases

Founded in early 2018, Uvax Bio, a spin-off vaccine company from Scripps Research

Verismo Therapeutics is pioneering the development of novel chimeric antigen receptors (CARs)

Headquartered in West Chester, PA, Verrica is led by a team rich in experience developing and commercializing dermatological treatments

At Vetigenics, we harness the power of the animal's own immune system to bring the latest advancements in biotechnology

Virion Therapeutics, LLC, is a science driven company developing innovative immune-based treatments for virally-associated cancers and chronic viral infections

Vitara is developing a therapeutic platform to support premature infants.  

Vivodyne accelerates the discovery of cures to human diseases with ultra-scalable drug testing on lab-grown human tissues.

Vyant Bio, Inc., a public company, is an innovative biotechnology company

Wuxi Biologics is a leading global open-access biologics technology platform offering end-to-end solutions

XyloCor Therapeutics is focused on improving the lives of people with cardiovascular disease through our commitment to advancing the science of gene therapy.

ZyVersa is a clinical stage specialty biopharmaceutical company that leverages advanced proprietary technologies to develop and commercialize